about
Reactivity of serotonin in whole blood: relationship with drug response in obsessive-compulsive disorder.Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.The Brief Obsessive-Compulsive Scale (BOCS): a self-report scale for OCD and obsessive-compulsive related disordersPoor motor skills: a risk marker for bully victimization.Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study.Autism spectrum disorder and low vitamin D at birth: a sibling control study.Internet-Based Cognitive Behavioral Therapy for Residual Symptoms in Bipolar Disorder Type II: A Single-Subject Design Pilot StudyChildhood clumsiness and peer victimization: a case-control study of psychiatric patients.Minor physical anomalies in adults with autism spectrum disorder and healthy controls.Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: relations with season, age, ethnic origin and psychiatric diagnosis.Vitamin D, light and mental health.The prevalence of lithium-associated hyperparathyroidism in a large Swedish population attending psychiatric outpatient units.[Suspect PANDAS in children with acute neuropsychiatric symptoms. Infection behind the disease - long-term antibiotic therapy should be considered].[Young woman dies of water intoxication after taking one tablet of ecstasy. Today's drug panorama calls for increased vigilance in health care]Exposure therapy and sertraline in social phobia: I-year follow-up of a randomised controlled trial.Panic disorder treated with the antihistamine chlorpheniramine.[Vitamin D and pregnancy: ethnocultural guidelines wanted].[The law of compulsory treatment of psychotic, somatically ill patients with HIV-1 infections][Increased occurrence of autism among Somali children--does vitamin D deficiency play a role?].Low prevalence of smoking among patients with obsessive-compulsive disorder.The extreme male brain revisited: gender coherence in adults with autism spectrum disorder.[Diagnosis and therapy are still challenging, despite the rapid growth of knowledge].Poor performance in physical education - a risk factor for bully victimization. A case-control study.Endocrine disruptors, the increase of autism spectrum disorder and its comorbidity with gender identity disorder--a hypothetical association.Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study.The potential of nutritional therapy.Focus on social functioning in depressionRelevance of Motor Skill Problems in Victims of Bullying[Vitamin D deficiency--who's responsibility?].[Why and when to vaccinate against meningococcal disease]Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine[Researchers and psychiatrists defending Gillberg's research on ADDH: Karfve's campaign is a form of personal persecution and scientific basis is missing]The treatment of social phobia in general practice. is exposure therapy feasible?[Vitamin D deficiency probably more common than earlier apprehended. Prevention and treatment could result in unexpected public health effects][Licensed preparations are required for normalization of vitamin D status][Vitamin D deficiency increases the cardiovascular risk. A hypothesis discussed for a long time now strongly supported by an epidemiologic study]
P50
Q32144286-5A66349A-07D7-402C-A4F4-CACED645FECAQ33972259-2EAC1060-9879-4E3F-80D1-4A9A5966F92BQ34456263-4EE950D7-2387-43AF-AAE6-786CFE85644DQ34470842-36D8AB41-BD6E-4B58-AE82-29558E27868FQ35073549-F3427596-8CFF-4BE2-BA4E-2E37C618A7C2Q35413717-E8960E3D-0969-4160-A4A6-79A70CBF9960Q35583013-876B304D-202E-4C81-A0EC-57AA34CC8000Q36698347-5D8D520F-942A-445B-8115-0A69C4E10CE3Q37695662-BE31FA11-35EE-46F7-A144-2FD353CC9BBDQ37705635-FA1E9134-7329-45C1-BF0F-9CB2006CC6A3Q37783690-D96A89C6-63F6-4105-8D3B-C7D3AEA30A13Q41101578-8EA1BC04-BA00-441E-BD37-69BFC92A26B7Q43523682-8A13278D-1FAF-4669-B5FD-0953CB8FF43EQ43551771-4D741968-0154-4DB2-B934-070F522DD0C8Q44385600-4689A288-F27A-4D21-AEDC-C31F55CA63FDQ44386450-BE222E8A-7DE7-42C8-A478-F27724F222C2Q44447074-1E30394A-7AA8-4312-9D85-054F5210C840Q44962898-D7D14382-7090-4255-9AF5-869BEF98A4B7Q46518215-EC5B8033-8298-4D0C-8965-BEA3007E498FQ48148839-B9D5112D-73EC-4C18-99B3-9661A1F164EAQ48569864-85A5DA33-CF61-4A04-9D81-F9BB97D289A6Q50301400-B069B6FB-7F5E-4482-889E-EE80F4CDC90CQ50301611-770FAB12-CF69-4DEB-9462-220D3D103052Q50346344-C1FB2B82-FB8D-41FA-9706-39EE4CD5B36BQ51034646-800A2AA9-58E5-4D85-9D73-FD6E58B5D271Q51857612-8D5ECDEB-9F7C-49FE-81E3-210BD548EF01Q57739369-A66C4732-4831-488A-B0C9-003192F61875Q61990044-168E3115-BA64-4CAD-A38D-C6AAC28B5D85Q64891401-70C37189-4156-4493-BBD1-7F7432CFBD77Q70503522-3A067E56-26EC-4C74-909C-AF614C5ABCBBQ72207766-31BF2879-3F8E-4D63-B3CB-E22C10C209C2Q73136441-FF881F0E-BF4C-4632-8669-37F240E50834Q73660547-20C9FC39-7AD2-4CBC-844E-2C211868EBC8Q80190111-0E4D1461-7948-49F1-B4A2-379EDE433392Q80644413-21D43201-322D-4784-8CE9-C66E91C26CB2Q81540173-F9ED3573-D986-42AA-8A9B-FA53FF88C2BF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mats B. Humble
@ast
Mats B. Humble
@en
Mats B. Humble
@es
Mats B. Humble
@nl
Mats B. Humble
@sl
type
label
Mats B. Humble
@ast
Mats B. Humble
@en
Mats B. Humble
@es
Mats B. Humble
@nl
Mats B. Humble
@sl
prefLabel
Mats B. Humble
@ast
Mats B. Humble
@en
Mats B. Humble
@es
Mats B. Humble
@nl
Mats B. Humble
@sl
P1053
B-3119-2013
P106
P1153
19734416900
P21
P31
P3829
P496
0000-0001-6726-7787